Parabilis Medicines Statistics
Total Valuation
PBLS has a market cap or net worth of $2.81 billion. The enterprise value is $1.74 billion.
| Market Cap | 2.81B |
| Enterprise Value | 1.74B |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026, before market open.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBLS has 123.53 million shares outstanding.
| Current Share Class | 121.95M |
| Shares Outstanding | 123.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +816.33% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 53.88% |
| Float | 82.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18,989.06 |
| Forward PS | 759.56 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11,737.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.91, with a Debt / Equity ratio of 0.05.
| Current Ratio | 17.91 |
| Quick Ratio | 17.83 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -139.58 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -15.42% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $1,021 |
| Profits Per Employee | -$1.60M |
| Employee Count | 145 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 35.09 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 24.61 |
| Average Volume (20 Days) | 977,855 |
Short Selling Information
The latest short interest is 8.26 million, so 6.69% of the outstanding shares have been sold short.
| Short Interest | 8.26M |
| Short Previous Month | 6.09M |
| Short % of Shares Out | 6.69% |
| Short % of Float | 10.07% |
| Short Ratio (days to cover) | 7.52 |
Income Statement
In the last 12 months, PBLS had revenue of $148,000 and -$231.67 million in losses. Loss per share was -$23.45.
| Revenue | 148,000 |
| Gross Profit | -12.95M |
| Operating Income | -171.54M |
| Pretax Income | -170.53M |
| Net Income | -231.67M |
| EBITDA | -169.11M |
| EBIT | -171.54M |
| Loss Per Share | -$23.45 |
Balance Sheet
The company has $1.12 billion in cash and $47.51 million in debt, with a net cash position of $1.07 billion or $8.69 per share.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 47.51M |
| Net Cash | 1.07B |
| Net Cash Per Share | $8.69 |
| Equity (Book Value) | 1.05B |
| Book Value Per Share | 8.48 |
| Working Capital | 1.06B |
Cash Flow
In the last 12 months, operating cash flow was -$111.29 million and capital expenditures -$1.20 million, giving a free cash flow of -$112.49 million.
| Operating Cash Flow | -111.29M |
| Capital Expenditures | -1.20M |
| Depreciation & Amortization | 2.43M |
| Net Borrowing | -10.61M |
| Free Cash Flow | -112.49M |
| FCF Per Share | -$0.91 |
Margins
| Gross Margin | n/a |
| Operating Margin | -115,907.43% |
| Pretax Margin | -115,224.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PBLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -8.24% |
| FCF Yield | -4.00% |
Analyst Forecast
The average price target for PBLS is $41.75, which is 83.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.75 |
| Price Target Difference | 83.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PBLS has an Altman Z-Score of 16.24 and a Piotroski F-Score of 1.
| Altman Z-Score | 16.24 |
| Piotroski F-Score | 1 |